# Matthias Briel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/matthias-briel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,973 |
| Field | Meta-analysis and systematic reviews |
| h-index | 78 |
| i10-index | 236 |
| Last Known Institution | University Hospital of Basel |
| OpenAlex ID | https://openalex.org/A5019888759 |
| ORCID iD | 0000-0002-2070-5230 |
| Works | 404 |

## Researcher papers

Showing 12 of 13.

- [Driving Pressure and Survival in the Acute Respiratory Distress Syndrome](https://scholariq.org/papers/driving-pressure-and-survival-in-the-acute-respiratory-distress-syndrome/)
- [Higher vs Lower Positive End-Expiratory Pressure in Patients With Acute Lung Injury and Acute Respiratory Distress Syndrome](https://scholariq.org/papers/higher-vs-lower-positive-end-expiratory-pressure-in-patients-with-acute-lung/)
- [Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials](https://scholariq.org/papers/bariatric-surgery-versus-non-surgical-treatment-for-obesity-a-systematic-review/)
- [Effects of Low-Carbohydrate vs Low-Fat Diets on Weight Loss and Cardiovascular Risk Factors](https://scholariq.org/papers/effects-of-low-carbohydrate-vs-low-fat-diets-on-weight-loss-and-cardiovascular/)
- [Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses](https://scholariq.org/papers/is-a-subgroup-effect-believable-updating-criteria-to-evaluate-the-credibility-of/)
- [Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses](https://scholariq.org/papers/development-of-the-instrument-to-assess-the-credibility-of-effect-modification/)
- [Randomized trials stopped early for benefit: a systematic review.](https://scholariq.org/papers/randomized-trials-stopped-early-for-benefit-a-systematic-review/)
- [Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections](https://scholariq.org/papers/procalcitonin-to-initiate-or-discontinue-antibiotics-in-acute-respiratory-tract/)
- [Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue \[<sup>90</sup>Y-DOTA\]-TOC in Metastasized Neuroendocrine Cancers](https://scholariq.org/papers/response-survival-and-long-term-toxicity-after-therapy-with-the-radiolabeled/)
- [Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis](https://scholariq.org/papers/association-between-change-in-high-density-lipoprotein-cholesterol-and/)
- [Credibility of claims of subgroup effects in randomised controlled trials: systematic review](https://scholariq.org/papers/credibility-of-claims-of-subgroup-effects-in-randomised-controlled-trials/)
- [First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data meta-analysis](https://scholariq.org/papers/first-line-treatment-and-outcome-of-elderly-patients-with-primary-central/)

## Researcher topics

- [Meta-analysis and systematic reviews](https://scholariq.org/topics/meta-analysis-and-systematic-reviews/)
- [Ethics in Clinical Research](https://scholariq.org/topics/ethics-in-clinical-research/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)
- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)

## Researcher university

- [University Hospital of Basel](https://scholariq.org/institutions/university-hospital-of-basel/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.